Prostate Biomarker Study

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Prostate Cancer
Interventions
OTHER

Questioners, blood specimens, prostate tissue specimens

"You will be asked to fill out a confidential questionnaire asking for information such as medical history, family history of cancer, and potential exposures.~Each patient will provide 7 unstained paraffin sections from prostate biopsies, one tube of blood for serum, and one tube for plasma and buffy coat."

OTHER

Questioners, blood specimens, prostate tissue specimens

"You will be asked to fill out a confidential questionnaire asking for information such as medical history, family history of cancer, and potential exposures.~Each patient will provide 7 unstained paraffin sections from prostate biopsies, one tube of blood for serum, and one tube for plasma and buffy coat."

Trial Locations (2)

10021

Memorial Sloan-Kettering Cancer Center, New York

90095

UCLA, Los Angeles

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Harvard University

OTHER

collaborator

Baylor College of Medicine

OTHER

collaborator

Dana-Farber Cancer Institute

OTHER

collaborator

University of Washington

OTHER

collaborator

Fred Hutchinson Cancer Center

OTHER

collaborator

Johns Hopkins University

OTHER

collaborator

Mayo Clinic

OTHER

collaborator

M.D. Anderson Cancer Center

OTHER

collaborator

Northwestern University

OTHER

collaborator

University of Michigan

OTHER

collaborator

University of California, San Francisco

OTHER

collaborator

University of California, Los Angeles

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00574899 - Prostate Biomarker Study | Biotech Hunter | Biotech Hunter